{"pmid":32419710,"pmcid":"PMC7224655","title":"Deep venous thrombosis in a non-critically ill patient with novel COVID-19 infection.","text":["Deep venous thrombosis in a non-critically ill patient with novel COVID-19 infection.","*COVID-19 infection is associated with hypercoagulability and a prothrombotic state.*Little is understood about the prevalence of venous thromboembolism in mild disease.*We present a case of mild COVID-19 complicated by extensive deep venous thrombosis.","Thromb Res","Nauka, Peter C","Oran, Erick","Chekuri, Sweta","32419710"],"abstract":["*COVID-19 infection is associated with hypercoagulability and a prothrombotic state.*Little is understood about the prevalence of venous thromboembolism in mild disease.*We present a case of mild COVID-19 complicated by extensive deep venous thrombosis."],"journal":"Thromb Res","authors":["Nauka, Peter C","Oran, Erick","Chekuri, Sweta"],"date":"2020-05-19T11:00:00Z","year":2020,"_id":"32419710","source":"PubMed","week":"202021|May 18 - May 24","doi":"10.1016/j.thromres.2020.05.015","topics":["Case Report"],"weight":1,"_version_":1667159284436172802,"score":9.490897,"similar":[{"pmid":32425264,"pmcid":"PMC7229939","title":"Severe arterial thrombosis associated with Covid-19 infection.","text":["Severe arterial thrombosis associated with Covid-19 infection.","*Increased incidence of venous thrombosis has been demonstrated in SARS-CoV2 infected patients but no data are available for arterial thrombosis.*We observed very severe arterial thrombotic complications in COVID-19 patients with cardiovascular history despite the use of antiplatelet or anticoagulant therapy, including five irreversible lower limb ischemia and two thoracic aortic free floating thrombi.*Three patients were in intensive care unit (ICU) and two of them also presented VTE, one deep vein thrombosis and one segmental PE.*Further studies are needed to evaluate the necessity of therapeutic anticoagulation in COVID-19 patients with peripheral arterial occlusive disease or thrombophilia.","Thromb Res","Kashi, Mahine","Jacquin, Aurelien","Dakhil, Bassel","Zaimi, Rym","Mahe, Emmanuel","Tella, Emilie","Bagan, Patrick","32425264"],"abstract":["*Increased incidence of venous thrombosis has been demonstrated in SARS-CoV2 infected patients but no data are available for arterial thrombosis.*We observed very severe arterial thrombotic complications in COVID-19 patients with cardiovascular history despite the use of antiplatelet or anticoagulant therapy, including five irreversible lower limb ischemia and two thoracic aortic free floating thrombi.*Three patients were in intensive care unit (ICU) and two of them also presented VTE, one deep vein thrombosis and one segmental PE.*Further studies are needed to evaluate the necessity of therapeutic anticoagulation in COVID-19 patients with peripheral arterial occlusive disease or thrombophilia."],"journal":"Thromb Res","authors":["Kashi, Mahine","Jacquin, Aurelien","Dakhil, Bassel","Zaimi, Rym","Mahe, Emmanuel","Tella, Emilie","Bagan, Patrick"],"date":"2020-05-20T11:00:00Z","year":2020,"_id":"32425264","source":"PubMed","week":"202021|May 18 - May 24","doi":"10.1016/j.thromres.2020.05.025","keywords":["arterial thrombosis","covid-19","floating aortic thrombus","lower limb ischemia","sars-cov2 infection"],"locations":["thoracic"],"topics":["Case Report"],"weight":1,"_version_":1667252837779767296,"score":139.59814},{"pmid":32399449,"pmcid":"PMC7213837","title":"Deep Vein Thrombosis and Pulmonary Embolism: Two Complications of COVID-19 Pneumonia?","text":["Deep Vein Thrombosis and Pulmonary Embolism: Two Complications of COVID-19 Pneumonia?","Coronavirus disease 19 (COVID-19) is a worldwide infection which was recently declared a global health emergency by the WHO Emergency Committee. The most common symptoms are fever and cough, which can progress to pneumonia, acute respiratory distress syndrome (ARDS) and/or end-organ failure. Risk factors associated with ARDS and death are older age, comorbidities (e.g., hypertension, diabetes, hyperlipidaemia), neutrophilia, and organ and coagulation dysfunction. Disseminated intravascular coagulation and coagulopathy can contribute to death. Anticoagulant treatment is associated with decreased mortality in severe COVID-19 pneumonia. In this report we describe two patients with COVID-19 pneumonia who developed venous thromboembolism. LEARNING POINTS: Deep vein thrombosis and pulmonary embolism can occur in patients with COVID-19 pneumonia.Low-molecular-weight heparin prophylaxis does not decrease the risk of venous thromboembolism (VTE) in COVID-19 pneumonia.In the presence of clinical signs and/or suspicion of VTE, compression ultrasound and echocardiography should be always performed, irrespective of disease stage.","Eur J Case Rep Intern Med","Poggiali, Erika","Bastoni, Davide","Ioannilli, Eva","Vercelli, Andrea","Magnacavallo, Andrea","32399449"],"abstract":["Coronavirus disease 19 (COVID-19) is a worldwide infection which was recently declared a global health emergency by the WHO Emergency Committee. The most common symptoms are fever and cough, which can progress to pneumonia, acute respiratory distress syndrome (ARDS) and/or end-organ failure. Risk factors associated with ARDS and death are older age, comorbidities (e.g., hypertension, diabetes, hyperlipidaemia), neutrophilia, and organ and coagulation dysfunction. Disseminated intravascular coagulation and coagulopathy can contribute to death. Anticoagulant treatment is associated with decreased mortality in severe COVID-19 pneumonia. In this report we describe two patients with COVID-19 pneumonia who developed venous thromboembolism. LEARNING POINTS: Deep vein thrombosis and pulmonary embolism can occur in patients with COVID-19 pneumonia.Low-molecular-weight heparin prophylaxis does not decrease the risk of venous thromboembolism (VTE) in COVID-19 pneumonia.In the presence of clinical signs and/or suspicion of VTE, compression ultrasound and echocardiography should be always performed, irrespective of disease stage."],"journal":"Eur J Case Rep Intern Med","authors":["Poggiali, Erika","Bastoni, Davide","Ioannilli, Eva","Vercelli, Andrea","Magnacavallo, Andrea"],"date":"2020-05-14T11:00:00Z","year":2020,"_id":"32399449","source":"PubMed","week":"202020|May 11 - May 17","doi":"10.12890/2020_001646","keywords":["covid-19 pneumonia","deep vein thrombosis","heparin","pulmonary embolism","venous thromboembolism"],"locations":["Pneumonia"],"e_drugs":["Heparin"],"topics":["Case Report"],"weight":1,"_version_":1666714494762483713,"score":138.56218},{"pmid":32306290,"pmcid":"PMC7165253","title":"Venous thrombosis and arteriosclerosis obliterans of lower extremities in a very severe patient with 2019 novel coronavirus disease: a case report.","text":["Venous thrombosis and arteriosclerosis obliterans of lower extremities in a very severe patient with 2019 novel coronavirus disease: a case report.","The outbreak of 2019 novel coronavirus disease (COVID-19) began since early December 2019, and has been declared as a public health emergency by the World Health Organization. Due to the hypercoagulable state, blood stasis and endothelial injury, severe patients with COVID-19 are at high risk for thrombosis. We report a case of very severe COVID-19 complicated with venous thrombosis and arteriosclerosis obliterans of lower extremities. Risk stratification for deep vein thrombosis and peripheral arterial disease are of vital importance for the prognosis of COVID-19.","J Thromb Thrombolysis","Zhou, Bo","She, Jianqing","Wang, Yadan","Ma, Xiancang","32306290"],"abstract":["The outbreak of 2019 novel coronavirus disease (COVID-19) began since early December 2019, and has been declared as a public health emergency by the World Health Organization. Due to the hypercoagulable state, blood stasis and endothelial injury, severe patients with COVID-19 are at high risk for thrombosis. We report a case of very severe COVID-19 complicated with venous thrombosis and arteriosclerosis obliterans of lower extremities. Risk stratification for deep vein thrombosis and peripheral arterial disease are of vital importance for the prognosis of COVID-19."],"journal":"J Thromb Thrombolysis","authors":["Zhou, Bo","She, Jianqing","Wang, Yadan","Ma, Xiancang"],"date":"2020-04-20T11:00:00Z","year":2020,"_id":"32306290","source":"PubMed","week":"202017|Apr 20 - Apr 26","doi":"10.1007/s11239-020-02084-w","keywords":["2019 novel coronavirus disease","arteriosclerosis obliterans","rhabdomyolysis","type 2 diabetes","venous thrombosis"],"topics":["Case Report"],"weight":1,"_version_":1666138493351362561,"score":134.73363},{"pmid":32399457,"pmcid":"PMC7213833","title":"Cerebral Venous Sinus Thrombosis as a Presentation of COVID-19.","text":["Cerebral Venous Sinus Thrombosis as a Presentation of COVID-19.","Coronavirus disease 19 (COVID-19) is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). We describe the case of a 59-year-old man who presented with headache, hypertension and a single episode of fever with no other symptoms. He subsequently developed unilateral weakness. Computer tomography identified a cerebral venous sinus thrombosis (CVST). A subsequent test for COVID-19 was positive. This is the first report of CVST as a presenting symptom of COVID-19 infection. LEARNING POINTS: Thrombotic events may be the initial presenting symptom of COVID-19.These thrombotic events include stroke, venous thromboembolism, pulmonary embolism and cardiac complications.Clinicians should carefully consider the risk of thrombosis in patients positive for COVID-19, including prophylaxis and treatment beyond discharge.","Eur J Case Rep Intern Med","Hughes, Christopher","Nichols, Tom","Pike, Martin","Subbe, Christian","Elghenzai, Salah","32399457"],"abstract":["Coronavirus disease 19 (COVID-19) is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). We describe the case of a 59-year-old man who presented with headache, hypertension and a single episode of fever with no other symptoms. He subsequently developed unilateral weakness. Computer tomography identified a cerebral venous sinus thrombosis (CVST). A subsequent test for COVID-19 was positive. This is the first report of CVST as a presenting symptom of COVID-19 infection. LEARNING POINTS: Thrombotic events may be the initial presenting symptom of COVID-19.These thrombotic events include stroke, venous thromboembolism, pulmonary embolism and cardiac complications.Clinicians should carefully consider the risk of thrombosis in patients positive for COVID-19, including prophylaxis and treatment beyond discharge."],"journal":"Eur J Case Rep Intern Med","authors":["Hughes, Christopher","Nichols, Tom","Pike, Martin","Subbe, Christian","Elghenzai, Salah"],"date":"2020-05-14T11:00:00Z","year":2020,"_id":"32399457","source":"PubMed","week":"202020|May 11 - May 17","doi":"10.12890/2020_001691","keywords":["covid-19","anticoagulation","cerebral venous sinus thrombosis","stroke"],"topics":["Case Report"],"weight":1,"_version_":1666865855101665280,"score":133.88734},{"pmid":32374544,"title":"[Venous thrombotic risk related to SARS-CoV-2 : prevalence, recommendations and perspectives].","text":["[Venous thrombotic risk related to SARS-CoV-2 : prevalence, recommendations and perspectives].","Since the SARS-CoV-2 pandemic outbreak, growing evidence suggests that patients suffering from COVID-19 are at increased risk of thrombotic events. The sepsis-related activation of the coagulation combined with a high prevalence of common thrombotic risk factors could contribute to this prothrombotic state. Coagulation biomarkers could help in the identification of patients at risk of complications and mortality. The incidence of venous thromboembolic events appears to be increased, especially in severe COVID-19 patients. Based on that knowledge, several societies have provided recommendation on the prevention of venous thromboembolism. In this narrative review, we summarize available epidemiologic data on venous thromboembolism and recommendations on thromboprophylaxis in COVID-19.","Rev Med Suisse","Casini, Alessandro","Fontana, Pierre","Glauser, Frederic","Robert-Ebadi, Helia","Righini, Marc","Blondon, Marc","32374544"],"abstract":["Since the SARS-CoV-2 pandemic outbreak, growing evidence suggests that patients suffering from COVID-19 are at increased risk of thrombotic events. The sepsis-related activation of the coagulation combined with a high prevalence of common thrombotic risk factors could contribute to this prothrombotic state. Coagulation biomarkers could help in the identification of patients at risk of complications and mortality. The incidence of venous thromboembolic events appears to be increased, especially in severe COVID-19 patients. Based on that knowledge, several societies have provided recommendation on the prevention of venous thromboembolism. In this narrative review, we summarize available epidemiologic data on venous thromboembolism and recommendations on thromboprophylaxis in COVID-19."],"journal":"Rev Med Suisse","authors":["Casini, Alessandro","Fontana, Pierre","Glauser, Frederic","Robert-Ebadi, Helia","Righini, Marc","Blondon, Marc"],"date":"2020-05-07T11:00:00Z","year":2020,"_id":"32374544","source":"PubMed","week":"202019|May 04 - May 10","locations":["thromboprophylaxis"],"topics":["Diagnosis","Treatment"],"weight":1,"_version_":1666138496341901312,"score":130.87682}]}